1 recruiting, 1 terminated, 1 unknown. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Recruiting 1, Terminated 1, Unknown 1 |
Follow CLL: new trials by email Literature Review of CLL trials Research Report on CLL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti CD19 CAR-T Combined With BTKi to Treat Newly Diagnosed High-risk CLL/SLL AntiCD19 CAR-T combined with BTKi in the treatment of newly diagnosed high-risk CLL/SLL patients - CLL, CAR-T Cell Therapy | Not applicable | Recruiting | The Affiliated Hospital of Xuzhou Medical University | 50 | 2025-09-01 | 2025-08-13 |
| Impact of Treatment With Targeted Therapies on the Generation of CAR T Cells in CLL Patients Peripheral blood samples withdrawal - CLL, Chronic Lymphocytic Leukemia | Not applicable | Unknown | Gruppo Italiano Malattie EMatologiche dell'Adulto | 23 | 2021-10-01 | 2022-01-04 |
| Hypertension Management in Cancer Patients Automated Messaging - Blood Pressure, Hypertension | Not applicable | Terminated | Duke University | 4 | 2019-12-10 | 2023-04-19 |
Breast Neoplasms (1) · Hematologic Neoplasms (1) · Hypertension (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Neoplasms (1) · Prostatic Neoplasms (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Breast Diseases (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, B-Cell (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1)
Duke University (1) · Gruppo Italiano Malattie EMatologiche dell'Adulto (1) · The Affiliated Hospital of Xuzhou Medical University (1)
China (1) · Italy (1) · United States (1)